There’s a lot to be optimistic about in the Consumer Goods sector as 2 analysts just weighed in on Synaptics Inc (SYNA) and Hain Celestial (HAIN) with bullish sentiments.
Synaptics Inc (SYNA)
In a report released today, Rajvindra Gill from Needham maintained a Buy rating on Synaptics Inc, with a price target of $60. The company’s shares closed yesterday at $40.86.
Gill observed:
“SYNA posted solid F2Q19 results but guided revenue below our reduced estimates, with revenue declining 15% Q/Q. The company experienced continued softness in IoT and Mobile, due to continued macro deterioration and uncertainty (China softness, smartphone unit weakness, etc). We expect a rebound in IoT in C2H19, as it launches its 22nm products and positive seasonality. We are encouraged by SYNA’ shift away from IoT , which we believe is a long-term growth driver. Also, the GM structure remains favorable, which is allowing EPS to grow.”
According to TipRanks.com, Gill is a 5-star analyst with an average return of 11.5% and a 55.6% success rate. Gill covers the Consumer Goods sector, focusing on stocks such as Everspin Technologies Inc, Smart Global Holdings Inc, and Adesto Technologies Corp.
Currently, the analyst consensus on Synaptics Inc is a Moderate Buy with an average price target of $47.60, a 16.5% upside from current levels. In a report issued on January 24, Tigress Financial also reiterated a Buy rating on the stock.
See today’s analyst top recommended stocks >>
Hain Celestial (HAIN)
Maxim Group analyst Anthony Vendetti maintained a Buy rating on Hain Celestial today and set a price target of $25. The company’s shares closed yesterday at $16.15, close to its 52-week low of $14.45.
Vendetti said:
“Market open, HAIN reported weaker-than-expected F2Q19 (Dec) results due to underperformance across all business segments. The company also slashed its FY19 (June) guidance as the new management team continues a major restructuring of the business. The sale of Hain Pure Protein (HPP) is delayed and is now likely to be sold in parts due to weakness in the segment’s turkey business, Plainville Farms. We expect short-term pain for HAIN, but believe the new management team is implementing the correct strategies for long-term gain. Although we are reducing our estimates and price target, we still view the stock as undervalued.”
According to TipRanks.com, Vendetti is a 4-star analyst with an average return of 4.8% and a 49.8% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Restoration Robotics Inc, Xtant Medical Holdings, and Ra Medical Systems Inc.
Hain Celestial has an analyst consensus of Hold, with a price target consensus of $24.18, a 49.7% upside from current levels. In a report released today, Jefferies also maintained a Buy rating on the stock with a $35 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
